3NA-66505-34885
3 vaccinations
5 coded responses
18 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 236 / VA
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Discomfort, Pruritus, Rash — Feeling: GoodFree text: Light, sparse rash on back appeated about four days ago - primarily extends from spine to the left and from waist to below bra-line. A few spots on the right side. Discomfort and slight itching.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Dose 2 — Pfizer-BioNTech
-
2021-02-25
Survey response — day 21, dose 2MedDRA: Limb discomfort — Feeling: GoodFree text: Leg discomfort at night has continued to return intermittently.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-11
- 2021-03-18
- 2021-05-06
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Abdominal discomfort — Feeling: FairFree text: Increased use of asthma inhaler due to heat/humidity levels. Increased gut distress over past three weeks.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-16
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-11-15
-
2022-02-14
Survey response — 6 months, dose 3MedDRA: Cough, Pre-existing disease — Feeling: GoodFree text: Increase in chronic cough I historically ascribed to pulmonary fibrous/asthmaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Survey response — 12 months, dose 3MedDRA: Gastrooesophageal reflux disease — Feeling: GoodFree text: Worsening GERD challengesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-08-16 | Pfizer-BioNTech | No |
Free text
Release 2 — day 14, dose 1
Symptoms: Light, sparse rash on back appeated about four days ago - primarily extends from spine to the left and from waist to below bra-line. A few spots on the right side. Discomfort and slight itching.
Release 4 — day 21, dose 2
Symptoms: Leg discomfort at night has continued to return intermittently.
Release 9 — 6 months, dose 2
Symptoms: Increased use of asthma inhaler due to heat/humidity levels. Increased gut distress over past three weeks.
Release 11 — 6 months, dose 3
Symptoms: Increase in chronic cough I historically ascribed to pulmonary fibrous/asthma
Release 12 — 12 months, dose 3
Symptoms: Worsening GERD challenges
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Discomfort | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Limb discomfort | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release